In a significant legal development, the state of Texas has filed a lawsuit against Kenvue and Johnson & Johnson, accusing the companies of concealing the potential risks associated with the use of Tylenol by pregnant women, particularly regarding links to autism and ADHD. The lawsuit claims that both companies knowingly withheld evidence that the active ingredient in Tylenol may be connected to these disorders. In response, Kenvue, a recent spinoff of Johnson & Johnson, has dismissed the allegations as unfounded, asserting that their medication is safe for expectant mothers. It also highlighted that the link between Tylenol usage during pregnancy and developmental issues like autism has not been definitively proven. Texas further alleges that the creation of Kenvue was a strategic move to protect Johnson & Johnson from liability related to potential risks posed by Tylenol.
In other news, homebuilder DR Horton has exceeded expectations for its quarterly home orders, buoyed by a decrease in mortgage rates that has encouraged buyers. Focused on the first-time buyer market, DR Horton has faced challenges due to ongoing affordability issues. To mitigate these challenges, the company and other builders have turned to discounting properties and providing incentives to stimulate sales.
Additionally, Trump Media is venturing into the prediction markets space, revealing plans to introduce prediction contracts on its Truth Social platform. These contracts will enable users to place bets on various events, including political elections and fluctuations in inflation rates. This move aligns with Trump Media’s broader strategy to leverage its retail following and respond to a surge in trading volume observed in leading prediction marketplaces such as Polymarket and Kalshi.
As a part of these ongoing developments, investors and analysts are encouraged to stay updated on stock performance trends through Yahoo Finance’s trending tickers page, accessible via the provided QR code.
